Back to results
US 8,557,592 B2Granted
Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant
AssigneeSysmex Corporation
InventorsMasahiro Okuda, Kazuyo Yoshida, Osamu Kumano
Life of this patent
Estimating the term…
Abstract
The present invention provides a reagent kit for detecting lupus anticoagulant which includes a first clotting time-measuring reagent containing manganese salt and a second clotting time-measuring reagent which contains manganese salt at a concentration lower than that of the first clotting time-measuring reagent or does not contain manganese salt and a method of determining the presence or absence of lupus anticoagulant using the kit.
Claims7
A reagent kit for detecting lupus anticoagulant comprising:
- a first clotting time-measuring reagent containing manganese salt, phospholipid and an activator for causing coagulation in vitro selected from the group consisting of ellagic acid, kaoline, cerite, and silica;
- a second clotting time-measuring reagent which contains manganese salt, phospholipid and an activator for causing coagulation in vitro selected from the group consisting of ellagic acid, kaoline, cerite, and silica, wherein a concentration of the manganese salt in the second clotting time-measuring reagent is lower than that of the first clotting time-measuring reagent or the second clotting time-measuring reagent does not contain manganese salt;
- and
- a third clotting time-measuring reagent containing calcium salt.
1 more element
A method of determining the presence or absence of lupus anticoagulant comprising steps of:
- providing a first specimen and a second specimen, both of which are taken from a same subject;
- mixing the first specimen with a first clotting time-measuring reagent containing manganese salt, phospholipid and an activator for causing coagulation in vitro selected from the group consisting of ellagic acid, kaoline cerite, and silica, and a third clotting time-measuring reagent containing calcium salt to measure a first clotting time;
- mixing the second specimen with a second clotting time-measuring reagent which contains manganese salt, phospholipid and an activator for causing coagulation in vitro selected from the group consisting of ellagic acid, kaoline, cerite and silica, and a fourth clotting time-measuring reagent containing calcium salt to measure a second clotting time, wherein a concentration of the manganese salt in the second clotting time-measuring reagent is lower than that of the first clotting time-measuring reagent or the second clotting time-measuring reagent does not contain manganese salt;
- and
- determining whether lupus anticoagulant is contained in the subject by determining whether the first clotting time is shortened relative to the second clotting time as an indicator of the existence of lupus anticoagulant.
2 more elements
Dependencies are inferred from the claim text.